Volume 3 Issue 4, April 1997

Less stress — more pressure?

• Robert A. Fishman

Less stress — more pressure?

• Hermona Soreq
• Daniela Kaufer
• Alon Friedman

To test, or not to test?

• Tom S. Frank

HIV-1 antibody — debris or virion?

• Paul W.H.I. Parren
• Dennis R. Burton
• Quentin J. Sattentau

HIV-1 — co-receptors binding

• Shibo Jiang

Transmission of L. infantum by blood donors

• Joanna Kubar
• Jean-François Quaranta
• Jean-Pierre Aufeuvre

Easier access to clinical trials

• Barbara J. Culliton

Hughes expands in the Americas

• Barbara J. Culliton

Reactions to cloning

• Marlene Cimons

… and home on the farm

• David Dickson

Japan considers ethics of genetic screening

• Richard Nathan

… and Britain considers impact on life insurance

• David Dickson

NY hospitals win education subsidy

• Barbara J. Culliton

HIV CCR5 resistance incomplete

• Orla Smith

Japan forges ahead on artificial organs

Rational design of vaccines

• Rino Rappuoli

Selectivity of general anesthetics: A new dimension

• Nicholas P. Franks
• William R. Lieb

Multidrug resistance — a multiplex phenomenon

• Nicola Baldini

Gene therapy for motor neuron disease

• Michael Sendtner

T lymphocytes: Setting the tone of the airways

• Erwin W. Gelfand
• Charles G. Irvin

Managed care for viruses

• Ronald G. Crystal

Fibrillation, chaos and clinical control

• Max J. Lab

Thyroiditis and hepatitis: Fas on the road to disease

• Lars E. French
• Jürg Tschopp

HIV accessory proteins as therapeutic targets

• Roger H. Miller
• Nava Sarver

Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines

• José M.P. Freije
• Julia A. Lawrence
• Patricia S. Steeg

Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice

• Karen A. Klein
• Robert E. Reiter
• Charles L. Sawyers

Essential roles of the Fas ligand in the development of hepatitis

• Toru Kondo
• Takashi Suda
• Shigekazu Nagata

Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein

• Lyuba Benimetskaya
• John D. Loike
• C.A. Stein

Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A

• Joseph P. Steiner
• Maureen A. Connolly
• Solomon H. Snyder

Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors

• G. Haase
• P. Kennel
• A. Kahn

Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth

• Toshihide Tanaka
• Yoshinobu Manome
• Howard A. Fine

Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470

• Nancy Klauber
• Richard M. Rohan
• Robert J. D'amato

Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression

• Ralf C. Bargou
• Karsten Jürchott
• Hans-Dieter Royer

Effective tumor vaccines generated by in vitro modification of tumor cells with cytokines and bispecific monoclonal antibodies

• Ya-Jun Guo
• Xiao-Yan Che
• Meng-Chao Wu

Elevation of oxygen release by nitroglycerin without an increase in blood flow in the hepatic microcirculation

• Hiroaki Kosaka
• Akitoshi Seiyama

T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice

• George T. De Sanctis
• Akihiko Itoh
• Jeffrey M. Drazen

The Eleventh Plague: The Politics of Biological and Chemical Warfare

Dying in a Japanese Hospital

Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis

• Stuart Mark Wilson
• Zubaida Al-Suwaidi
• Francis Drobniewski

On the market